APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enteric Viral Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enteric Viral Testing Market Outlook and Growth Opportunities 2026

Report ID 17443609054 July 2026190 pages

Choose your research edition.

Industry ResearchEnteric Viral Testing Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Enteric Viral Testing Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Enteric Viral Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enteric Viral Testing Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Enteric Viral Testing Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global Enteric Viral Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enteric Viral Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enteric Viral Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enteric Viral Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enteric Viral Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enteric Viral Testing market include Qiagen, Abbott, Luminex, Roche, Thermo Fisher Scientific and Biofire Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Enteric Viral Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enteric Viral Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enteric Viral Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Enteric Viral Testing market.

Enteric Viral Testing Segment by Company

Qiagen

Abbott

Luminex

Roche

Thermo Fisher Scientific

Biofire Diagnostics

Enteric Viral Testing Segment by Type

Enzyme-Linked Immunosorbent Assay

Polymerase Chain Reaction

Reverse Transcription Polymerase Chain Reaction

Next-Generation Sequencing

Multiplex Pcr

Electron Microscopy

Serological Testing

Enteric Viral Testing Segment by Application

Research Institution

Hospital

Clinic

Enteric Viral Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enteric Viral Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Enteric Viral Testing key companies, revenue, market share, and recent developments.

3. To split the Enteric Viral Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Enteric Viral Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enteric Viral Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Enteric Viral Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric Viral Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enteric Viral Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric Viral Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enteric Viral Testing industry.

Chapter 3: Detailed analysis of Enteric Viral Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Enteric Viral Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Enteric Viral Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enteric Viral Testing Industry Trends Table 2. Enteric Viral Testing Industry Drivers Table 3. Enteric Viral Testing Industry Opportunities and Challenges Table 4. Enteric Viral Testing Industry Restraints Table 5. Global Enteric Viral Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enteric Viral Testing Revenue Share by Company (2021-2026) Table 7. Global Enteric Viral Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Enteric Viral Testing Key Company Manufacturing Base & Headquarters Table 9. Global Enteric Viral Testing Company, Product Type & Application Table 10. Global Enteric Viral Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Enteric Viral Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Enzyme-Linked Immunosorbent Assay Table 15. Significant Companies of Polymerase Chain Reaction Table 16. Significant Companies of Reverse Transcription Polymerase Chain Reaction Table 17. Significant Companies of Next-Generation Sequencing Table 18. Significant Companies of Multiplex Pcr Table 19. Significant Companies of Electron Microscopy Table 20. Significant Companies of Serological Testing Table 21. Global Enteric Viral Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Enteric Viral Testing Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Enteric Viral Testing Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Enteric Viral Testing Sales Value Share by Type (2021-2026) Table 25. Global Enteric Viral Testing Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Research Institution Table 27. Significant Companies of Hospital Table 28. Significant Companies of Clinic Table 29. Global Enteric Viral Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Enteric Viral Testing Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Enteric Viral Testing Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Enteric Viral Testing Sales Value Share by Application (2021-2026) Table 33. Global Enteric Viral Testing Sales Value Share by Application (2027-2032) Table 34. Global Enteric Viral Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Enteric Viral Testing Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Enteric Viral Testing Sales Value Share by Region (2021-2026) Table 37. Global Enteric Viral Testing Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Enteric Viral Testing Sales Value Share by Region (2027-2032) Table 39. Global Enteric Viral Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Enteric Viral Testing Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Enteric Viral Testing Sales Value Market Share by Country (2021-2026) Table 42. Global Enteric Viral Testing Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Enteric Viral Testing Sales Value Market Share by Country (2027-2032) Table 44. Qiagen Company Information Table 45. Qiagen Business Overview Table 46. Qiagen Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Qiagen Enteric Viral Testing Product Portfolio Table 48. Qiagen Recent Development Table 49. Abbott Company Information Table 50. Abbott Business Overview Table 51. Abbott Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Abbott Enteric Viral Testing Product Portfolio Table 53. Abbott Recent Development Table 54. Luminex Company Information Table 55. Luminex Business Overview Table 56. Luminex Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Luminex Enteric Viral Testing Product Portfolio Table 58. Luminex Recent Development Table 59. Roche Company Information Table 60. Roche Business Overview Table 61. Roche Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Roche Enteric Viral Testing Product Portfolio Table 63. Roche Recent Development Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Enteric Viral Testing Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Biofire Diagnostics Company Information Table 70. Biofire Diagnostics Business Overview Table 71. Biofire Diagnostics Enteric Viral Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Biofire Diagnostics Enteric Viral Testing Product Portfolio Table 73. Biofire Diagnostics Recent Development Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Enteric Viral Testing Product Image Figure 2. Global Enteric Viral Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enteric Viral Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Enteric Viral Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Enzyme-Linked Immunosorbent Assay Image Figure 8. Polymerase Chain Reaction Image Figure 9. Reverse Transcription Polymerase Chain Reaction Image Figure 10. Next-Generation Sequencing Image Figure 11. Multiplex Pcr Image Figure 12. Electron Microscopy Image Figure 13. Serological Testing Image Figure 14. Global Enteric Viral Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Enteric Viral Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Enteric Viral Testing Sales Value Share by Type (2021-2032) Figure 17. Research Institution Image Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Enteric Viral Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Enteric Viral Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Enteric Viral Testing Sales Value Share by Application (2021-2032) Figure 23. Global Enteric Viral Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Enteric Viral Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Enteric Viral Testing Sales Value (2021-2032) & (US$ Million) Figure 26. North America Enteric Viral Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Enteric Viral Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Enteric Viral Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Enteric Viral Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Enteric Viral Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Enteric Viral Testing Sales Value (2021-2032) & (US$ Million) Figure 32. South America Enteric Viral Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Enteric Viral Testing Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Enteric Viral Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Enteric Viral Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Enzyme-Linked Immunosorbent Assay
  • Polymerase Chain Reaction
  • Reverse Transcription Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Multiplex Pcr
  • Electron Microscopy
  • Serological Testing
Applications
  • Research Institution
  • Hospital
  • Clinic
Companies covered
  • Qiagen
  • Abbott
  • Luminex
  • Roche
  • Thermo Fisher Scientific
  • Biofire Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enteric Viral Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enteric Viral Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Enteric Viral Testing Market Dynamics
  1. 2.1 Enteric Viral Testing Industry Trends
  2. 2.2 Enteric Viral Testing Industry Drivers
  3. 2.3 Enteric Viral Testing Industry Opportunities and Challenges
  4. 2.4 Enteric Viral Testing Industry Restraints
3 Enteric Viral Testing Market by Company
  1. 3.1 Global Enteric Viral Testing Company Revenue Ranking in 2025
  2. 3.2 Global Enteric Viral Testing Revenue by Company (2021-2026)
  3. 3.3 Global Enteric Viral Testing Company Ranking (2024-2026)
  4. 3.4 Global Enteric Viral Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Enteric Viral Testing Company Product Type and Application
  6. 3.6 Global Enteric Viral Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Enteric Viral Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Enteric Viral Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Enteric Viral Testing Market by Type
  1. 4.1 Enteric Viral Testing Type Introduction
  2. 4.1.1 Enzyme-Linked Immunosorbent Assay
  3. 4.1.2 Polymerase Chain Reaction
  4. 4.1.3 Reverse Transcription Polymerase Chain Reaction
  5. 4.1.4 Next-Generation Sequencing
  6. 4.1.5 Multiplex Pcr
  7. 4.1.6 Electron Microscopy
  8. 4.1.7 Serological Testing
  9. 4.2 Global Enteric Viral Testing Sales Value by Type
  10. 4.2.1 Global Enteric Viral Testing Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Enteric Viral Testing Sales Value by Type (2021-2032)
  12. 4.2.3 Global Enteric Viral Testing Sales Value Share by Type (2021-2032)
5 Enteric Viral Testing Market by Application
  1. 5.1 Enteric Viral Testing Application Introduction
  2. 5.1.1 Research Institution
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Enteric Viral Testing Sales Value by Application
  6. 5.2.1 Global Enteric Viral Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enteric Viral Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Enteric Viral Testing Sales Value Share by Application (2021-2032)
6 Enteric Viral Testing Regional Value Analysis
  1. 6.1 Global Enteric Viral Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enteric Viral Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Enteric Viral Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Enteric Viral Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enteric Viral Testing Sales Value (2021-2032)
  7. 6.3.2 North America Enteric Viral Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Enteric Viral Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Enteric Viral Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Enteric Viral Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Enteric Viral Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Enteric Viral Testing Sales Value (2021-2032)
  16. 6.6.2 South America Enteric Viral Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Enteric Viral Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Enteric Viral Testing Sales Value Share by Country, 2025 VS 2032
7 Enteric Viral Testing Country-level Value Analysis
  1. 7.1 Global Enteric Viral Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enteric Viral Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Enteric Viral Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Enteric Viral Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Enteric Viral Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Enteric Viral Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Enteric Viral Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qiagen
  2. 8.1.1 Qiagen Company Information
  3. 8.1.2 Qiagen Business Overview
  4. 8.1.3 Qiagen Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qiagen Enteric Viral Testing Product Portfolio
  6. 8.1.5 Qiagen Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Enteric Viral Testing Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Luminex
  14. 8.3.1 Luminex Company Information
  15. 8.3.2 Luminex Business Overview
  16. 8.3.3 Luminex Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Luminex Enteric Viral Testing Product Portfolio
  18. 8.3.5 Luminex Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Enteric Viral Testing Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Enteric Viral Testing Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Biofire Diagnostics
  32. 8.6.1 Biofire Diagnostics Company Information
  33. 8.6.2 Biofire Diagnostics Business Overview
  34. 8.6.3 Biofire Diagnostics Enteric Viral Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biofire Diagnostics Enteric Viral Testing Product Portfolio
  36. 8.6.5 Biofire Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst